Northern Trust’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$89.6M Buy
1,586,384
+38,419
+2% +$2.24M 0.01% 794
2025
Q4
$92M Sell
1,547,965
-114,303
-7% -$6.22M 0.01% 777
2025
Q3
$90M Buy
1,662,268
+7,157
+0.4% +$409K 0.01% 787
2025
Q2
$91M Sell
1,655,111
-41,753
-2% -$2.46M 0.01% 754
2025
Q1
$120M Sell
1,696,864
-28,175
-2% -$1.9M 0.02% 643
2024
Q4
$113M Buy
1,725,039
+240,681
+16% +$16.1M 0.02% 662
2024
Q3
$104M Sell
1,484,358
-93,901
-6% -$7.85M 0.02% 630
2024
Q2
$130M Buy
1,578,259
+500,230
+46% +$41.6M 0.02% 535
2024
Q1
$94.2M Sell
1,078,029
-72,754
-6% -$6.51M 0.02% 655
2023
Q4
$111M Sell
1,150,783
-69,031
-6% -$6.11M 0.02% 588
2023
Q3
$108M Buy
1,219,814
+43,695
+4% +$3.89M 0.02% 568
2023
Q2
$102M Sell
1,176,119
-129,319
-10% -$12.2M 0.02% 588
2023
Q1
$127M Buy
1,305,438
+248
+0% +$25.7K 0.03% 527
2022
Q4
$135M Buy
1,305,190
+11,683
+0.9% +$1.1M 0.03% 500
2022
Q3
$110M Sell
1,293,507
-11,020
-0.8% -$981K 0.03% 514
2022
Q2
$108M Sell
1,304,527
-21,927
-2% -$1.75M 0.02% 542
2022
Q1
$102M Sell
1,326,454
-37,047
-3% -$3.1M 0.02% 636
2021
Q4
$120M Buy
1,363,501
+8,188
+0.6% +$676K 0.02% 607
2021
Q3
$105M Buy
1,355,313
+70,868
+6% +$5.59M 0.02% 638
2021
Q2
$107M Buy
1,284,445
+69,449
+6% +$5.51M 0.02% 645
2021
Q1
$91.7M Buy
1,214,996
+30,432
+3% +$2.49M 0.02% 713
2020
Q4
$104M Sell
1,184,564
-36,355
-3% -$2.88M 0.02% 627
2020
Q3
$92.9M Sell
1,220,919
-73,890
-6% -$7.48M 0.02% 592
2020
Q2
$160M Buy
1,294,809
+72,606
+6% +$7.22M 0.04% 404
2020
Q1
$103M Buy
1,222,203
+83,344
+7% +$7.18M 0.03% 462
2019
Q4
$96.3M Sell
1,138,859
-53,379
-4% -$4.03M 0.02% 604
2019
Q3
$80.4M Sell
1,192,238
-24,025
-2% -$1.85M 0.02% 656
2019
Q2
$104M Buy
1,216,263
+13,949
+1% +$1.19M 0.02% 563
2019
Q1
$107M Buy
1,202,314
+20,108
+2% +$1.86M 0.03% 534
2018
Q4
$101M Buy
1,182,206
+75,550
+7% +$7.19M 0.03% 515
2018
Q3
$107M Sell
1,106,656
-2,407
-0.2% -$240K 0.03% 530
2018
Q2
$104M Buy
1,109,063
+12,326
+1% +$1.08M 0.03% 540
2018
Q1
$88.9M Sell
1,096,737
-13,295
-1% -$1.14M 0.02% 607
2017
Q4
$99M Buy
1,110,032
+5,952
+0.5% +$518K 0.03% 571
2017
Q3
$103M Buy
1,104,080
+6,509
+0.6% +$575K 0.03% 540
2017
Q2
$99.7M Buy
1,097,571
+31,113
+3% +$2.83M 0.03% 529
2017
Q1
$93.6M Buy
1,066,458
+26,940
+3% +$2.4M 0.03% 553
2016
Q4
$86.1M Sell
1,039,518
-254,800
-20% -$21.9M 0.03% 559
2016
Q3
$120M Buy
1,294,318
+83,584
+7% +$7.87M 0.04% 439
2016
Q2
$94.2M Buy
1,210,734
+44,857
+4% +$3.81M 0.03% 514
2016
Q1
$103M Buy
1,165,877
+31,645
+3% +$2.57M 0.03% 470
2015
Q4
$119M Sell
1,134,232
-70,385
-6% -$7.35M 0.04% 420
2015
Q3
$127M Sell
1,204,617
-73,119
-6% -$9.77M 0.04% 408
2015
Q2
$175M Sell
1,277,736
-55,657
-4% -$6.9M 0.05% 339
2015
Q1
$166M Buy
1,333,393
+33,852
+3% +$3.59M 0.05% 355
2014
Q4
$117M Buy
1,299,541
+43,797
+3% +$3.64M 0.04% 450
2014
Q3
$90.6M Buy
1,255,744
+235,662
+23% +$15.5M 0.03% 512
2014
Q2
$63.5M Sell
1,020,082
-430,486
-30% -$26M 0.02% 660
2014
Q1
$98.9M Buy
1,450,568
+259,007
+22% +$19.1M 0.03% 494
2013
Q4
$83.8M Buy
1,191,561
+71,015
+6% +$4.82M 0.03% 518
2013
Q3
$80.9M Buy
1,120,546
+5,316
+0.5% +$353K 0.03% 498
2013
Q2
$62.2M Buy
+1,115,230
New +$69.5M 0.02% 565

Other funds holding BMRN